Abstract. This study determined the immunolocalization of transforming growth factor-β1 (TGF-β1) in the ovarian follicles of the adult mouse at diestrus, proestrus and estrus (10 and 12.5 h after treatment with hCG). The majority (≥72%) of the oocytes were stained positive in type 3b through to type 8 follicles. TGF-β1 staining in the granulosa and theca cells was first observed in type 5b follicles. The percentage of follicles with positively stained granulosa cells increased with follicular development from type 6 to 8 (13 to 82%). The percentage of follicles with positively stained theca cells did not show a clear trend (~30%) up to 10 h after hCG treatment, but increased in type 7 (79%) and unovulated type 8 (55%) follicles during the ovulation period (12.5 h after hCG). These results indicate that TGF-β1 is involved in follicular development and differentiation. ransforming growth factor-β1 (TGF-β1) is a member of the TGF superfamily of molecules that regulate proliferation, differentiation, migration and adhesion of a wide variety of cell types [1] . In the ovary, three TGF-β isoforms (β1, β2 and β3) exhibit cell type-specific patterns of expression and differential responsiveness to hormonal stimulation [2] [3] [4] [5] [6] [7] .
ransforming growth factor-β1 (TGF-β1) is a member of the TGF superfamily of molecules that regulate proliferation, differentiation, migration and adhesion of a wide variety of cell types [1] . In the ovary, three TGF-β isoforms (β1, β2 and β3) exhibit cell type-specific patterns of expression and differential responsiveness to hormonal stimulation [2] [3] [4] [5] [6] [7] .
The potential significance of TGF-β1 in ovarian physiology is highlighted by its ability to promote proliferation and differentiation in isolated in vitro cultured granulosa [8] [9] [10] [11] [12] and theca-interstitial cells [13, 14] , but there have been few studies on the physiological role of TGF-β1 in follicular development in vivo, even though TGF-β1 administration has been shown to inhibit ovulation in gonadotropinprimed mice [15] .
TGF-β1 immunoreactivity has been detected in oocytes, granulosa and theca cells of human [4] , hamster [5] , rat [6] and immature mouse [7] follicles, whereas TGF-β1 is only localized in the interstitial-glandular cells of adult mice [16] , so that localization of TGF-β1 in the ovarian follicles is inconsistent in previous reports. Furthermore, previous reports did not focus on the changes in immunohistochemical staining patterns of TGF-β1 in the estrous stages and follicular development stages.
In an effort to understand the role of TGF-β1 in o va r ian ph ysiolo gy, w e exam ined TG F-β 1 immunolocalization in the specific stages of follicles in mice at diestrus, proestrus and after treatment with hCG to clarify the changes in the staining patterns during follicular development.
Materials and Methods

Animals and treatment
Seven-week-old female ICR mice purchased from Japan SLC Inc. (Hamamatsu, Shizuoka, Japan) were housed in a temperature-and light-controlled room with a 14 h light: 10 h dark photoperiod and provided with feed and water ad libitum. The mice were handled according to guidelines laid down by the university. The estrous-cycle stage was confirmed by examination of vaginal smears once daily between 0800 and 0900 h in the morning. After at least two consecutive estrous cycles, ovaries were recovered from two mice each at diestrus and proestrus between 0900 and 1000 h. In another group, the mice were injected with 5 IU hCG (Gonatropin, Teikoku Hormone Mfg. Co. Ltd., Tokyo, Japan) intraperitoneally between 1200 and 1300 h on the day of proestrus. Ovaries were recovered from two mice at 10 h and two mice at 12.5 h after hCG injection.
Immunohistochemistry
Recovered ovaries were fixed in Bouin's solution for 12 h and were processed through an alcohol series before being embedded in paraffin. Whole ovaries were serially sectioned at 5 µm. Every fifth s e c t i o n o f t h e o v a r i e s w a s u s e d f o r immunohistochemistry. The immunostaining was done according to instructions supplied with the staining kit (Histofine, Nichirei Corporation, Tokyo, Japan), consisting of normal goat serum, goat anti-rabbit IgG conjugated with biotin (secondary antibody) and streptavidin-peroxidase complex. Briefly, after deparaffinization and rinsing in Dulbecco's phosphate-buffered saline (PBS), ovarian sections were incubated with 3% hydrogen peroxide in methanol for 10 min at room temperature. Subsequent steps were carried out at 4 C, and the sections were rinsed 3 times for 5 min in PBS between steps. Sections were incubated with normal goat serum for 10 min followed by a rabbit-raised polyclonal anti-human TGF-β1 antibody (SC-146, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at a dilution of 1:10 for 24 h. They were then incubated with the second antibody and streptavidin-peroxidase complex for 10 and 5 min, respectively. Sections were incubated with 0.03% diaminobenzidine-tetrahydrochloride (Wako Pure Chemical Industries Ltd., Osaka, Japan) and 0.01% hydrogen peroxide dissolved in 0.05 M Tris-HCl buffer (pH 7.6) for 20 min. The ovarian sections that served as negative controls were incubated without the anti-TGF-β1 antibody. For positive controls, sections of mouse adrenal glands were used.
Immunoreactivity for TGF-β1 was judged as p o s i t i v e w h e n t h e s i g n a l w a s c l e a r l y distinguishable from the background and as n e g a t i v e w h e n t h e s i g n a l w a s a b s e n t o r indistinguishable from the background. Sections with poor immunostaining due to artifacts were excluded. TGF-β1 immunoreactivity was assessed on the section showing the largest cross-sections of the follicles of different types determined according to the classification described by Pedersen and Peters [17] .
Results
In the preliminary experiment, the degree of n o n s p e c i f i c b i n d i n g o f T G F -β 1 a n t i b o d y determined by background staining did not show an obvious increase from 1:1000 to 1:5 dilution. Be cause the TGF-β1 signal beca me clear ly distinguishable at 1:10, the dilution rate of 1:10 was used throughout the present study.
Ovulation was observed on tissue sections of ovaries recovered at 12.5 h after hCG treatment. The interstitial cells and corpora lutea showed positive staining for TGF-β1. Oocytes in type 3a follicles had negative TGF-β1 staining at all estrous stages. Oocyte staining was observed from type 3b and was positive in the majority (≥72%) of follicles from type 3b to type 8 (Fig. 1a) .
Regardless of the estrous stage, positive TGF-β1 staining in the granulosa cells was first observed in type 5b follicles. As shown in Table 1 , the percentages of follicles with positively stained granulosa cells in type 6 and type 7 follicles was higher (p<0.05) than those of type 5b, except at 12.5 h after hCG injection. Positively stained theca cells were observed from type 5b to type 8 follicles. Although the percentage of type 6 follicles with positively stained theca cells was higher (p<0.05) than that of type 5b at diestrus and after hCG treatment, no further increase in the percentage of follicles with positively stained theca cells was observed from type 6 to type 8 at any estrous stage.
When follicle-staining patterns (Fig. 1b-c) in the granulosa and theca cells of type 6 at diestrus, type 7 at proestrus, and type 8 at 10 h after the hCG treatment were compared, the percentage of follicles with positively stained granulosa cells increased (p<0.05) with follicular development b e f o r e o v u l a t i o n ( 1 3 . 3 , 4 6 . 4 a n d 8 2 . 4 % , respectively). There were no differences in the percentages of follicles with positively stained theca cells among those 3 types of follicles (30.0, 28.6 and 29.4%, respectively). At 12.5 h after hCG treatment, the percentage of type 8 follicles with positively stained granulosa cells decreased (9.1%), whereas that with positive-stained theca cells increased (54.5%).
As shown in Table 2 , the majority of type 6 and 7 follicles (63 and 46%, respectively) were judged to have negatively stained granulosa and theca cells. The proportion of follicles with positively stained granulosa cells and negatively stained theca cells increased (p<0.05) as follicles developed from type 6 to 8, and the majority (58.8%) of type 8 follicles at 10 h after the hCG treatment had this staining pattern. After 12.5 h of hCG treatment (during the ovulation period), type 8 follicles either had negative staining in both compartments (45.4%) or had negatively stained granulosa cells and positively stained theca cells (45.4%).
Discussion
The presence of TGF-β1 in the granulosa cells just before the time of antrum formation (type 5b) is in agreement with a previous report [7] in which TGF-β1 protein expression was observed in the granulosa cells of immature mouse antral to preovulatory follicles without specifying the follicle types. The increase in the proportion of follicles with positively stained granulosa cells from the early antral (type 6) to the preovulatory (type 8) stage indicated that TGF-β1 expression increased with follicular development. This finding is supported by the increase in TGF-β1 mRNA expression with follicle development [18] , and s u g g e s t s t h a t T G F -β 1 i s i n v o l v e d i n t h e development and differentiation of mouse granulosa cells.
At the time of antrum formation, estradiol production begins to increase in intact mouse follicles cultured in vitro [19] . TGF-β1 increases FSH-induced cAMP [20] , aromatase activity and estrogen production [8, 21] in rat granulosa cells cultured in vitro. Furthermore, LH binding sites are present in the mural granulosa cells of mouse preovulatory follicles in vivo [22] . TGF-β1 expression is consistent with its ability to promote FSH-induced LH receptor expression in granulosa cells in vitro [11, 20] . It was suggested that reduction of LH receptor expression caused by TGF-β1 may lessen the ability of granulosa cells to respond to LH during ovarian follicular maturation and ovulation [20] . The trend in TGF-β1 staining patterns in early antral to preovulatory follicles suggested that follicles which would eventually ovulate should have positively stained granulosa cells.
The appearance of positive staining in theca cells around the time of antrum formation is consistent with previous reports on the rat [6] and immature mouse [7] . These previous studies focused on the regulation of TGF-β1 expression by gonadotropins and did not determine the specific follicle types. In the present study, the high proportions of retarded type 7 (78.9%) and unruptured type 8 (54.5%) follicles with positively stained theca cells at 12.5 h after hCG treatment, might have been attributable to both hCG treatment and the in vivo LH surge. h C G h a s b e e n s h o w n t o p r o m o t e T G F -β 1 expression in the theca cells of mouse preovulatory follicles [7] . TGF-β1 inhibits androgen production and promotes progesterone production in the in vitro cultured rat theca-interstitial cells by decreasing the activity of cytochrome P45017α [13] . Because corpora lutea were positively stained in the present and previous studies in the human [4] , rat [6] and mouse [7] , the follicles showing theca TGF-β1 staining at 12.5 h after hCG treatment in the pr es en t stud y m ay h ave be e n un de r go ing luteinization. But the typical theca cell staining pattern of follicles which will eventually ovulate and/or undergo atresia is not yet clear.
Immunohistochemical studies have shown the expression of TGF-β1 in the oocytes of the hamster [5] , rat [6] and mouse [7] without specifying the follicle stage. In the present study, the appearance of TGF-β1 immunoreactivity in the oocytes coincided with the transformation of primary (type 3a) to secondary (type 3b) follicles, and this is in agreement with the findings in the rat, in which oocyte staining for TGF-β1 was first observed in the follicles with 2-3 layers of granulosa cells [6] . Because at this stage of follicle development the oocyte begins to grow, TGF-β1 may play a role in regulating oocyte development. The present study and previous studies in the human [4] , hamster [5] , r a t [ 6 ] a n d m o u s e [ 7 ] d e m o n s t r a t e d t h e immunolocalization of TGF-β1 in the oocyte. It is likely that the oocyte is a site of TGF-β1 synthesis, but neither TGF-β1 protein [16] nor specific mRNA [18] expression was reported in the oocytes at any stage of follicles in the mouse. Therefore, further studies on oocyte specific mRNA expression with in situ PCR are necessary to clarify the source of oocyte TGF-β1.
In conclusion, we have demonstrated for the first time the changes in the immunohistochemical staining patterns of TGF-β1 of mouse ovarian follicles according to follicular development and the estrous stage. The increase in the proportion of follicles with positively stained granulosa/theca cells according to follicle development indicates that TGF-β1 participates in follicular development and differentiation.
